Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival
Investigators from Cedars-Sinai Cancer have identified an investigational therapeutic approach that could be effective against treatment-resistant prostate cancer. Results of their Phase II clinical trial, published in Molecular ...
Nov 2, 2022
0
73